Celyad (fka Cardio3 BioSciences) is Profiled in this Database

Updated At 14 Dec, 2016

Partial description of this company

1-Bio-therapeutic designed from autologous stem cells and committed to a cardiac lineage before implantation, 2-Corresponding catheter for accurate transmyocardial injection

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Celyad (fka Cardio3 BioSciences) plus 4709 other start-ups.

Start Free 7 Day Trial Now

Learn More About Celyad (fka Cardio3 BioSciences)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation